Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 22, 2022NutrientsOpen Access

Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future

View Full Paper
Ask AI
Bookmark
Share

Authors

VBVincent BrandenburgKlinikum RheineMKMarkus KettelerRobert Bosch Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Brandenburg et al. (2022) studied this question.

synapsesocial.com/papers/6a7de9ecc108c8d3ff045fabhttps://doi.org/10.3390/nu14153009
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism2016 · 24 citations
  2. 2Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies2018 · 120 citations
  3. 319-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis.1998 · 346 citations
  4. 4Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes – Data from a randomized, placebo-controlled study2022 · 31 citations
  5. 5KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease2020 · 1,413 citations